Benjamin Chien

Benjamin Chien is the founder of Theracor Pharmaceuticals, Inc. (founded in 2003), QPS LLC (founded in 1995), and Foresee Pharmaceuticals Co., Ltd. (founded in 2013).
He currently holds the position of Chairman, President & Chief Executive Officer at QPS Holdings LLC.
He is also the Chairman of Qualitix Clinical Research Co., Ltd., Unitix Clinical Research Co. Ltd., and Director of QPS Netherlands BV and Quest Pharmaceutical Services.
Additionally, he is a Director at XDD Acquisition BV, Foresee Pharmaceuticals Usa, Inc., Foreseeacer Pharmaceuticals, Inc., QPS Austria GmbH, Qps Group Holdings LLC, Bkca LLC, Kuale Tisi Shanghai Medical Co. Information Consultation, Qps Shanghai Co. Ltd., Qps Suzhou Co. Ltd., QPS MRA, and Foresee Pharmaceuticals LLC.
Dr. Chien has previously held the position of Chairman & Chief Executive Officer at QPS Holdings LLC, Director at Delaware BioScience Association, and Principal at DuPont Merck Pharmaceutical Co. He holds a doctorate degree from the University of Michigan, a graduate degree from National Cheng Kung University, and a doctorate degree from National Taiwan Normal University.